Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Dow
Express Scripts
Merck
Harvard Business School

Last Updated: January 29, 2020

DrugPatentWatch Database Preview

LIDOCAINE HYDROCHLORIDE VISCOUS Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Lidocaine Hydrochloride Viscous, and what generic alternatives are available?

Lidocaine Hydrochloride Viscous is a drug marketed by Actavis Mid Atlantic, Intl Medication, and Lannett Co Inc. and is included in three NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE VISCOUS is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Lidocaine Hydrochloride Viscous

A generic version of LIDOCAINE HYDROCHLORIDE VISCOUS was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on January 29th, 2020.

  Start Trial

Drug patent expirations by year for LIDOCAINE HYDROCHLORIDE VISCOUS
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE VISCOUS

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Lawrence Charles HookeyN/A
Harvard UniversityPhase 2
University of Colorado, DenverPhase 2

See all LIDOCAINE HYDROCHLORIDE VISCOUS clinical trials

Pharmacology for LIDOCAINE HYDROCHLORIDE VISCOUS
Synonyms for LIDOCAINE HYDROCHLORIDE VISCOUS
(unlabeled)Lidocaine-d6 Hydrochloride
137-58-6 (Parent)
2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide hydrochloride
2-(diethylamino)-N-(2,6-dimethylphenyl)ethanamide hydrochloride
2-Diethylamino-2',6'-acetoxylidide hydrochloride
2',6'-ACETOXYLIDIDE, 2-(DIETHYLAMINO)-, HYDROCHLORIDE
2',6'-Acetoxylidide, 2-(diethylamino)-, monohydrochloride
2',6'-Acetoxylidide, 2-(diethylamino)-, monohydrochloride (8CI)
73-78-9
A837924
AC-11712
AC1L1M96
AC1Q5LY0
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, hydrochloride (1:1)
Acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl)-, monohydrochloride
AK326167
AKOS015889456
alpha-Diethylamino-2,6-acetoxylidine hydrochloride
ALPHACAINE HCL
ALPHACAINE HYDROCHLORIDE
Anestacon hydrochloride
API0003175
AS-35171
BC203198
C14H22N2O.HCl
CCG-39281
CHEBI:50512
CHEMBL541521
CS-3888
CTK8G0579
D02086
Dalcaine (TN)
Diethylamino-2,6-dimethylacetanilide Hydrochloride
DTXSID4058782
Duncaine hydrochloride
EC2CNF7XFP
EINECS 200-803-8
EU-0100669
FT-0603276
Glydo
Gravocain hydrochloride
HMS1568I21
HMS1921C22
HY-B0185A
I01-2012
I01-4416
Isicaine hydrochloride
IYBQHJMYDGVZRY-UHFFFAOYSA-N
KS-00001F6P
L 5647
Laryng-O-jet
LARYNG-O-JET KIT
LARYNGOTRACHEAL ANESTHESIA KIT
Leostesin hydrochloride
Lidoca ne hydrochloride
Lidocain hydrochloride
Lidocaine (hydrochloride)
LIDOCAINE HCL
LIDOCAINE HCL 0.1% AND DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 0.2% IN DEXTROSE 5%
LIDOCAINE HCL 0.2% IN DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 0.4% IN DEXTROSE 5%
LIDOCAINE HCL 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 0.8% AND DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 0.8% IN DEXTROSE 5% IN PLASTIC CONTAINER
LIDOCAINE HCL 5% AND DEXTROSE 7.5%
LIDOCAINE HCL IN PLASTIC CONTAINER
LIDOCAINE HCL PRESERVATIVE FREE
LIDOCAINE HCL PRESERVATIVE FREE IN PLASTIC CONTAINER
LIDOCAINE HCL VISCOUS
Lidocaine hydrochloride
Lidocaine Hydrochloride (anhydrous)
Lidocaine hydrochloride (JAN/USP)
Lidocaine hydrochloride 0.1% and dextrose 5% in plastic container
Lidocaine hydrochloride 0.2% and dextrose 5% in plastic container
Lidocaine hydrochloride 0.2% in dextrose 5%
Lidocaine hydrochloride 0.2% in dextrose 5% in plastic container
Lidocaine hydrochloride 0.4% and dextrose 5% in plastic container
Lidocaine hydrochloride 0.4% in dextrose 5%
Lidocaine hydrochloride 0.4% in dextrose 5% in plastic container
Lidocaine hydrochloride 0.8% and dextrose 5% in plastic container
Lidocaine hydrochloride 0.8% in dextrose 5% in plastic container
Lidocaine hydrochloride 5% and dextrose 7.5%
Lidocaine hydrochloride anhydrous
Lidocaine hydrochloride in plastic container
Lidocaine hydrochloride preservative free
Lidocaine hydrochloride preservative free in plastic container
lidocaine hydrochloride(jan/usp)
Lidocaine injection (JP17)
LIDOCAINE VISCOUS
Lidocaine(hydrochloride)
lidocainehydrochloride
Lidocaton
LIDOPEN
Lidothesin
Lidothesin hydrochloride
Lignocaine hydrochloride
Linocaine hydrochloride
LP00669
LS-13898
LTA II KIT
MLS000069665
MolPort-003-666-319
N-(Diethylaminoacetyl)-2,6-dimethylaniline hydrochloride
NCGC00094030-01
NCGC00094030-02
NCGC00094030-03
NCGC00094030-04
NCGC00094030-05
NCGC00261354-01
NSC-757420
NSC757420
omega-Diethylamino-2,6-dimethylacetanilide hydrochloride
Opera_ID_351
PEDIATRIC LTA KIT
Pharmakon1600-01500689
Prestwick_296
Q-201304
Rucaina hydrochloride
S 202
s4667
SB19119
SMR000058468
SPECTRUM1500689
SR-01000000189
SR-01000000189-3
SR-01000000189-9
Tox21_500669
UNII-EC2CNF7XFP
V 262
Xilina hydrochloride
Xycaine hydrochloride
Xylestesin hydrochloride
Xylocaine (TN)
XYLOCAINE 1.5% W/ DEXTROSE 7.5%
XYLOCAINE 4% PRESERVATIVE FREE
XYLOCAINE 5% W/ GLUCOSE 7.5%
Xylocaine hydrochloride
XYLOCAINE PRESERVATIVE FREE
Xylocard
Xylocitin hydrochloride
Xyloneural
Xylotox hydrochloride
Zingo

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE VISCOUS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 086578-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Intl Medication LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 086389-001 Feb 2, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc LIDOCAINE HYDROCHLORIDE VISCOUS lidocaine hydrochloride SOLUTION;ORAL 040708-001 Feb 27, 2007 AT RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Express Scripts
AstraZeneca
Colorcon
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.